Recent Company News

• 05:10 AM ET Oct 29, 2025
  

  Evotec SE to Announce Results for The First Nine Months 2025 on 05 November 2025

• 04:15 AM ET Sep 04, 2025
  

  StreetAccount Summary - Trading higher/lower: EU mid-morning

• 03:46 AM ET Oct 27, 2025
  

  StreetAccount Summary - European pre-market trading update

• 02:50 AM ET Oct 27, 2025
  

  Evotec Announces Progress in Preclinical Neuroscience Partnership with Bristol Myers Squibb

• 02:33 AM ET Oct 27, 2025
  

  Evotec receives $25M payment from Bristol Myers Squibb for scientific progress achieved within their strategic neuroscience partnership (€6.97, 0.00)

• 04:27 AM ET Oct 22, 2025
  

  Evotec announces partner Dewpoint Therapeutics announces an open IND for first-in-class condensate modulator DPTX3186 for Wnt-driven cancers (€6.77, -0.05)

• 08:11 AM ET Oct 16, 2025
  

  Evotec's collaboration with Esperion leads to nomination of preclinical development candidate for treatment of Primary Sclerosing Cholangitis (€6.81, +0.09)

• 01:49 AM ET Sep 04, 2025
  

  Index changes: GEA Group and Scout24 added to DAX Index, Sartorius and Porsche deleted, changes effective 22-Sep (3-Sep, post EU close)

• 06:30 AM ET Aug 27, 2025
  

  StreetAccount Summary - European unusual volume traders